Yale Study Confirms Ketamine Treatment as the Safest Long-Term Procedure
Researchers at Yale recently published a study called ‘Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment’. Back in 2014, Yale provided Ketamine therapy as an off-label procedure to different patients and on a case-to-case basis.
As per the Samuel T. Wilkinson, MD at Yale School of Medicine and Psychiatric Hospital;
Ketamine has been used as an off-label procedure to treat depression by many providers. Indeed, there is a very small amount of long-term data on individuals who received Ketamine therapy for